Fig. 7

Promoter methylation level of HOXB9 is upregulated in EC. A HOXB9 promoter methylation levels of EC patients from TCGA analyzed by UALCAN. B–H: Subgroup analysis of multiple clinicopathological characteristics about HOXB9 promoter methylation level. B patient’s age. C patient’s race. D patient’s weight. E histological subtype. F individual cancer stage. G tumor grade. H TP53 mutation status (*: P value < 0.05; **: P value < 0.01; ***: P value < 0.001)